Valeant Pharmaceuticals International, Inc. (VRX) Stock Price Hits 52-Week High Today

Cornelia Mascio
Dicembre 11, 2017

The Vnbtrust National Association holds 141,339 shares with $4.41 million value, down from 197,194 last quarter. Liberty Global Plc now has $29.83 billion valuation. (NYSE VRX) traded up $2.07 during trading on Friday, reaching $19.70. About 44.86M shares traded or 224.44% up from the average.

Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has declined 48.51% since December 9, 2016 and is downtrending. It has underperformed by 23.48% the S&P500. (NYSE:VRX) or 3,000 shares. (NYSE:VRX). Peak6 Limited Partnership invested in 0% or 22,661 shares. It has outperformed by 64.15% the S&P500. Finally, Vetr lowered Valeant Pharmaceuticals International from a "strong-buy" rating to a "sell" rating and set a $13.30 price objective for the a report on Thursday, August 24th. Therefore 0 are positive. Valeant Pharmaceuticals International had 36 analyst reports since October 20, 2015 according to SRatingsIntel.

Partnervest Advisory Services LLC lessened its position in shares of Valeant Pharmaceuticals International, Inc. The rating was maintained by Mizuho on Tuesday, November 7 with "Sell". The company was maintained on Wednesday, July 19 by Stifel Nicolaus. Seaport Global maintained Stepan Company (NYSE:SCL) on Wednesday, August 24 with "Neutral" rating. On Tuesday, September 20 the stock rating was initiated by Deutsche Bank with "Hold". The firm has "Buy" rating given on Friday, July 28 by Cantor Fitzgerald. H.C. Wainwright maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to report earnings on February, 27. The firm has "Sell" rating by Mizuho given on Wednesday, November 1. Industrial Alliance Securities upgraded Stepan Company (NYSE:SCL) on Monday, May 29 to "Strong Buy" rating.

This represents a decrease of -9% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks. Its down 0.16, from 1.24 in 2017Q1. US Bancorp DE lifted its holdings in Valeant Pharmaceuticals International by 418.4% in the 2nd quarter. 49 funds opened positions while 90 raised stakes. 4,227 are owned by Piedmont Invest Advsr Ltd Co. Commonwealth Equity holds 0.01% or 47,423 shares in its portfolio. Next Finance Gp reported 0% stake. (NYSE:VRX). 175,000 are held by Phoenix Adviser Ltd Liability Company. Franklin Resource reported 267,546 shares or 0% of all its holdings. Bridgewater LP invested in 0.01% or 70,269 shares. 171.89 million shares or 1.47% more from 169.41 million shares in 2017Q1 were reported. The company has market cap of $6.87 billion. 31,998 were accumulated by Guggenheim Capital Ltd Liability Corp. Public Sector Pension Investment Board owns 642,017 shares or 0.1% of their USA portfolio. Hudock Gru Limited Com stated it has 18 shares. Acadian Asset Management Ltd Company owns 768,929 shares. 12 were accumulated by Exchange Capital Management. Janney Montgomery Scott Ltd Llc holds 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) for 968,221 shares. Natixis has invested 0% of its portfolio in Valeant Pharmaceuticals International, Inc. (NYSE:VRX) or 370,246 shares.

Since June 9, 2017, it had 0 buys, and 1 sale for $360,700 activity. Stifel Nicolaus has "Buy" rating and $55 target. Therefore 88% are positive. Stepan Co had 12 analyst reports since August 26, 2015 according to SRatingsIntel. (NYSE:RNG) earned "Outperform" rating by Oppenheimer on Wednesday, December 16. The firm has "Sector Perform" rating by RBC Capital Markets given on Tuesday, October 25. Morgan Stanley downgraded RingCentral, Inc. The stock presently has a consensus rating of "Hold" and a consensus target price of $17.46. As per Thursday, November 9, the company rating was maintained by Northland Capital. Suntrust Robinson initiated the stock with "Buy" rating in Tuesday, June 27 report. Barclays Capital maintained the shares of VRX in report on Friday, February 10 with "Equal Weight" rating. Its up 0.34, from 0.97 in 2017Q1. 40 funds opened positions while 57 raised stakes. Blackrock holds 0% of its portfolio in Valeant Pharmaceuticals International, Inc. Nationwide Fund reported 0.02% in RingCentral, Inc. Can lifted its holdings in Valeant Pharmaceuticals International by 2.0% in the 2nd quarter. (NYSE:RNG) for 22,758 shares. 3,500 were reported by Mai Capital Mgmt. IL now owns 72,866 shares of the specialty pharmaceutical company's stock worth $1,261,000 after acquiring an additional 26,865 shares during the period. Swiss Bankshares accumulated 92,100 shares or 0% of the stock. Manufacturers Life The, Ontario - Canada-based fund reported 294,968 shares. Cubist Systematic Strategies Ltd Liability holds 0.01% or 2,648 shares in its portfolio. Invesco Ltd holds 1.71 million shares or 0.01% of its portfolio. Ngam Advisors Ltd Partnership owns 53,538 shares or 0.02% of their U.S. portfolio. Financial Bank Of New York Mellon Corporation holds 0% or 277,717 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE